US2016102066A1PendingUtilityA1

Benzothiazole derivative and anti-tumor use thereof

24
Assignee: UNIV YANTAIPriority: Oct 9, 2014Filed: May 22, 2015Published: Apr 14, 2016
Est. expiryOct 9, 2034(~8.2 yrs left)· nominal 20-yr term from priority
A61P 35/00C07D 277/82
24
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a benzothiazole derivative of formula 1 or a pharmaceutically acceptable salt thereof and a process for preparation thereof. The present invention also relates to a pharmaceutical composition comprising the compounds and the use of the compounds in the preparation of an anti-tumor medicament.

Claims

exact text as granted — not AI-modified
1 - 7 . (canceled) 
     
     
         8 . A method for treating a cancer associated with abnormal activity of TRPC6 comprising administering an effective amount of a compound which is 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt or prodrug thereof to a subject in need thereof. 
     
     
         9 . The method according to  claim 8 , wherein the cancer is selected from breast cancer, lung cancer, prostate cancer and oral epithelium carcinoma.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.